Expertise in
13
conditions

Dr. Jeffrey J. Pu

Hematology
Tufts Medical Center Cancer Center
860 Washington St Fl 8, 
Boston, MA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
32 Years of Experience
Expertise in
13
conditions
Tufts Medical Center Cancer Center
860 Washington St Fl 8, 
Boston, MA 

Overview

Jeffrey Pu is a Hematologist practicing medicine in Boston, Massachusetts. He has been practicing medicine for over 32 years.

Dr. Pu is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Acute Erythroid Leukemia (AEL), Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 48 peer reviewed articles and participating in 2 clinical trials. Dr. Pu is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in PA

Hospital Affiliations

Tufts Medical Center
Melrosewakefield Healthcare

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Tufts Medical Center Cancer Center
860 Washington St Fl 8, Boston, MA 02111

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL
A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL
Enrollment Status: Recruiting
Publish Date: September 02, 2026
Intervention Type: Biological, Drug, Procedure, Other
Study Drugs: Allopurinol, Cytarabine, Daunorubicin Hydrochloride, Vincristine Sulfate, Dexamethasone, Pegylated L-Asparaginase, Methotrexate, Cyclophosphamide, Mercaptopurine, Rituximab, Doxorubicin, Thioguanine, Inotuzumab
Study Phase: Phase 3
Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma: A Phase I/II Study (PSHCI 10-011)
Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma: A Phase I/II Study (PSHCI 10-011)
Enrollment Status: Unknown
Publish Date: August 07, 2017
Intervention Type: Drug
Study Drugs: Rituximab, Bortezomib, Cladribine
Study Phase: Phase 1
View 1 Less Clinical Trial

48 Total Publications

Correction: PIGN spatiotemporally regulates the spindle assembly checkpoint proteins in leukemia transformation and progression.
Correction: PIGN spatiotemporally regulates the spindle assembly checkpoint proteins in leukemia transformation and progression.
Journal: Scientific reports
Published: June 03, 2026
Similar Doctors
Expertise in
18
conditions
Dr. Steven G. Dubois
Hematology | Oncology
Expertise in
18
conditions
Dr. Steven G. Dubois
Hematology | Oncology
Referral may be required

Dana-Farber Cancer Institute

450 Brookline Ave, 
Boston, MA 
 (2.7 miles away)
877-442-3324
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Steven Dubois is a Hematologist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Dubois is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Ewing Sarcoma, Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Osteosarcoma. Dr. Dubois is currently accepting new patients.

Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required

Dana-Farber Cancer Institute

450 Brookline Ave, 
Boston, MA 
 (2.7 miles away)
877-442-3324
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Corey Cutler is a Hematologist practicing medicine in Boston, Massachusetts. Dr. Cutler is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Graft. Dr. Cutler is currently accepting new patients.

Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required

Tufts Medical Center Hematology

860 Washington St Bldg 7, 
Boston, MA 
 (0.1 miles away)
617-263-8312
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Raymond Comenzo is a Hematologist practicing medicine in Boston, Massachusetts. Dr. Comenzo is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Primary Amyloidosis, Multiple Myeloma, Cardiac Amyloidosis, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Comenzo is currently accepting new patients.

Frequently Asked Questions about Dr. Jeffrey J. Pu

How do I make an appointment with Dr. Jeffrey J. Pu?

You can book an appointment with Dr. Jeffrey J. Pu by calling their office at 617-636-6106. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jeffrey J. Pu a top-rated expert for Mantle Cell Lymphoma (MCL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey J. Pu is classified as an Distinguished expert for Mantle Cell Lymphoma (MCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jeffrey J. Pu specialize in?

While Dr. Jeffrey J. Pu is a Hematology, they have specific expertise in Mantle Cell Lymphoma (MCL), Acute Erythroid Leukemia (AEL), and Acute Myeloid Leukemia (AML). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Jeffrey J. Pu participate in research or clinical trials?

Yes. Dr. Jeffrey J. Pu has published 48 articles and abstracts on conditions like Mantle Cell Lymphoma (MCL). You can view a list of Dr. Jeffrey J. Pu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pu's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 58 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile